Literature DB >> 22847384

Stroke: Expanded indications for stroke thrombolysis--what next?

Geoffrey A Donnan, Stephen M Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22847384     DOI： 10.1038/nrneurol.2012.151

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Third international stroke trial.

Authors:  William Whiteley; Richard Lindley; Joanna Wardlaw; Peter Sandercock
Journal:  Int J Stroke       Date:  2006-08       Impact factor: 5.266

Review 2.  Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.

Authors:  Stephen M Davis; Geoffrey A Donnan
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

3.  Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase.

Authors:  Jochen B Fiebach; Yasir Al-Rawi; Max Wintermark; Anthony J Furlan; Howard A Rowley; Annika Lindstén; Jamal Smyej; Paul Eng; Steven Warach; Salvador Pedraza
Journal:  Stroke       Date:  2012-04-03       Impact factor: 7.914

4.  A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.

Authors:  Mark Parsons; Neil Spratt; Andrew Bivard; Bruce Campbell; Kong Chung; Ferdinand Miteff; Bill O'Brien; Christopher Bladin; Patrick McElduff; Chris Allen; Grant Bateman; Geoffrey Donnan; Stephen Davis; Christopher Levi
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

5.  A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).

Authors:  Henry Ma; Mark W Parsons; Soren Christensen; Bruce C V Campbell; Leonid Churilov; Alan Connelly; Bernard Yan; Chris Bladin; Than Phan; Alan P Barber; Stephen Read; Graeme J Hankey; Romesh Markus; Tissa Wijeratne; R Grimley; N Mahant; Tim Kleinig; John Sturm; A Lee; D Blacker; Richard Gerraty; M Krause; P M Desmond; S J McBride; Leanne Carey; David W Howells; C Y Hsu; Stephen M Davis; Geoffrey A Donnan
Journal:  Int J Stroke       Date:  2012-01       Impact factor: 5.266

Review 6.  Plasminogen activation and thrombolysis for ischemic stroke.

Authors:  Robert L Medcalf; Stephen M Davis
Journal:  Int J Stroke       Date:  2012-03-30       Impact factor: 5.266

Review 7.  Stroke.

Authors:  Geoffrey A Donnan; Marc Fisher; Malcolm Macleod; Stephen M Davis
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

8.  Statistical analysis plan for the third International Stroke Trial (IST-3); part of a 'thread' of reports of the trial.

Authors:  Peter Sandercock; Richard Lindley; Joanna Wardlaw; Will Whiteley; Gordon Murray
Journal:  Int J Stroke       Date:  2012-04       Impact factor: 5.266

9.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

Review 10.  Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory del Zoppo; Peter Sandercock; Richard L Lindley; Geoff Cohen
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321
  10 in total
  3 in total

1.  Effects of thrombolysis within 6 hours on acute cerebral infarction in an improved rat embolic middle cerebral artery occlusion model for ischaemic stroke.

Authors:  Zhihua Si; Jinzhi Liu; Ke Hu; Yan Lin; Jie Liu; Aihua Wang
Journal:  J Cell Mol Med       Date:  2019-01-29       Impact factor: 5.310

Review 2.  Therapeutic antibodies in stroke.

Authors:  Chye Yun Yu; Gandi Ng; Ping Liao
Journal:  Transl Stroke Res       Date:  2013-08-16       Impact factor: 6.829

Review 3.  The dual roles of autophagy and the GPCRs-mediating autophagy signaling pathway after cerebral ischemic stroke.

Authors:  Weichen Hou; Yulei Hao; Li Sun; Yang Zhao; Xiangyu Zheng; Lei Song
Journal:  Mol Brain       Date:  2022-02-02       Impact factor: 4.041
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.